Company intelligence / Profile preview

白云山

Ownership: Private
Employees: ~1300
Development stage: Commercial

Overview

A leading Chinese pharmaceutical manufacturer with commercialized products in male health, neurology and antibiotics. Recent achievements include generic Sildenafil Citrate exceeding ¥1B sales[6], dapoxetine approval creating 'twin stars' in male medicine[6], and novel cephalosporin development.

Therapeutic areas: Infectious DiseasesRheumatologyNeurologyMen's Health
Modalities: Small moleculesTraditional Chinese MedicineGeneric drugs
Industry: Biotech

Partnerships

Nobel Laureate Dr. Ferid Murad ('Viagra Father')

Beyond the preview

Go deeper on 白云山.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 白云山.

Explore the full profile